TCMBANKIN001801 |
miraxanthin iii |
|
C17H18N2O5 |
330.33 g/mol |
C1C(NC(=CC1=CC=NCCC2=CC=C(C=C2)O)C(=O)O)C(=O)O |
TCMBANKIN003939 |
miraxanthin ii |
|
C13H14N2O8 |
326.26 g/mol |
C1C(NC(=CC1=CC=NC(CC(=O)O)C(=O)O)C(=O)O)C(=O)O |
TCMBANKIN004126 |
vulgaxanthin ii |
|
C14H16N2O8 |
340.28 g/mol |
C1C(NC(=CC1=CC=NC(CCC(=O)O)C(=O)O)C(=O)O)C(=O)O |
TCMBANKIN013526 |
indicine |
|
C15H25NO5 |
299.36 g/mol |
CC(C)C(C(C)O)(C(=O)OCC1=CCN2C1C(CC2)O)O |
TCMBANKIN017954 |
miraxanthin i |
|
C14H18N2O7S |
358.37 g/mol |
CS(=O)CCC(C(=O)O)N=CC=C1CC(NC(=C1)C(=O)O)C(=O)O |
TCMBANKIN022214 |
Indicaxanthin |
indicaxanthin; (2S)-1-[(2E)-2-[(2S)-2,6-dicarboxy-2,3-dihydro-1H-pyridin-4-ylidene]ethylidene]pyrrolidin-1-ium-2-carboxylate; 2181-75-1; SCHEMBL288232; AC1O1I0D; C08549; CHEBI:5896; (1Z,2S)-1-{(2E)-2-[(2S)-2,6-Dicarboxy-2,3-dihydro-4(1H)-pyridinylidene]ethylidene}-2-pyrrolidinium carboxylate (Indicaxanthin) |
C14H16N2O6 |
308.29 |
C1CC([N+](=CC=C2CC(NC(=C2)C(=O)O)C(=O)O)C1)C(=O)[O-] |
TCMBANKIN022807 |
miroestrol |
|
C20H22O6 |
358.4 g/mol |
CC1(C2CC3(CC(=O)C(C2C3O)(C4=COC5=C(C41)C=CC(=C5)O)O)O)C |
TCMBANKIN033992 |
miraxanthin v |
|
C17H18N2O6 |
346.3 g/mol |
C1C(NC(=CC1=CC=NCCC2=CC(=C(C=C2)O)O)C(=O)O)C(=O)O |
TCMBANKIN041928 |
9-O-Methyl-4-hydroxyboeravinone |
|
|
|
|
TCMBANKIN050232 |
2′-O-Methylabronisoflavone |
|
|
|
|
TCMBANKIN061888 |
Ptelein |
6-methoxy dictamnine;BRN 0616297; 6-Methoxydictamnine; 4,6-dimethoxyfuro[2,3-b]quinoline; 6-Methoxy dictamine; CCRIS 3580; Furo(2,3-b)quinoline, 4,6-dimethoxy-; Pteleine; 2221-41-2 |
C13H11NO3 |
229.23 |
COC1=CC2=C(C=C1)N=C3C(=C2OC)C=CO3 |